Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001274173-25-000194·JANUS HENDERSON GROUP PLC
Schedule 13G ownership disclosure
TRAVERE THERAPEUTICS INC
Common Stock · CUSIP: 89422G107
Event date: 2025-07-31
- Filing-level shares
- 11,339,864
- Percent of class
- 12.8%
- JANUS HENDERSON GROUP PLC
Shares: 11,339,864 · Class: 12.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001274173-25-000194
- Form type
- SCHEDULE 13G/A
- Filer
- JANUS HENDERSON GROUP PLC
- CIK
- CIK 1274173
- Filed
- Aug 07, 2025
- Reporting period
- Jul 31, 2025
- Description
- Schedule 13G beneficial ownership